eFisioterapia

FIBROMIALGIA BIBLIOGRAFÍA

FUNDAMENTACIÓN TEÓRICA

1. Yunus MB, Masi AT, Calabro JJ, Miller KA, Feigenbaun SL. Clinical study of 50 patients and matched normal controls. Semin Arthritis Rheum 1981;11:1511-171.
2. Dra. Inmaculada Calvo Penadés.”Fibromialgia y otras formas de dolor musculoesquelético”
3. Buskila D, Gladman DD, Langevitz P, UrowitzS, Smythe HA. Fibromyalgia in human inmunodeficiency virus infection. J Rheumatol 1990;17:1202-1206.
4. Sigal LH. Summary of the first 100 patients seen at a Lyme disease referral center. Am J Med 1990;88:577-581.
5. 8ª. Conferencia de Fibromialgia "Una visión internacional – últimas investigaciones” Celebrada en el Salón de Actos de UGT de Madrid. 20 de Junio de 2003. Teresa Martín de los Reyes Presidenta de AFIBROM (Asociación de Fibromialgia de la Comunidad de Madrid) y Dr. D. Manuel Martínez-Lavín, ,Jefe del Servicio de Reumatología del Instituto de Cardiología de Méjico.
6. Moldofsky H, Scarisbrick P, England R, et al.: Musculoskeletal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med 1975, 37:341–351.
7. Wolfe F. Fibromyalgia: the clinical syndrome. Rheum Dis Clin North Am 1989; 15: 1-18.
8. Document on Fibromyalgia: The Copenhagen Declaration (1993). Journal of Musculoskeletal Pain. Vol. 1. Nueva York: The Haworth Press Inc., 1993
9. Goldenberg DL. Fibromyalgia syndrome. An emerging but controversial condition. JAMA 1987; 257:2782-7
10. Hudson JL, Pope HG. Fibromyalgia and psychopathology: is fibromyalgia a form of affective spectrum disorder? J Rheumatol 1989; 19: 5-22
11. Yunus MB, Masi AT, Aldag Jc. A controlled sudy of primary fibromyalgia syndrome: clinical features and association with other functional syndromes. J Rheumatol 1989; 19: (supl):62-71
12. Wolfe F, Ross K, Anderson J, Russell IJ. Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 1995; 22: 151-6
13. Veale D, Kavanagh G, Fielding JF, Fitzgerald O. Primary fibromyalgia and the irritable bowel syndrome: different expressions of a common pathogenic process. Br J Rheumatol 1991; 30: 220-2.
14. "La Fibromialgia, los Trastornos Funcionales Digestivos y la Depresión" Universidad de la República, Cátedra de Reumatología Dra. M. Moyano

( www.sitiomedico.com.uy/artnac/2002/02/24.htm )

Richter JE, Barish Cf, Castell DO. Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology 1986; 91:845.

1. Clouse RE, et al. Clinical correlates of abnormal sensitivity to intraesophageal balloon distention. Dig Dis Sci 1991;36:1040
2. Mayer EA, Raybould HE. Role of visceral afferent mechanisms in functional bowel disorders. Gastroenterology 1990;99:1688.
3. Savio LY Woo et al. Injury and repair of the musculoskeletal soft tissues. American Academy of Orthopaedic Surgeons, Illinois, 1991
4. Bienfait M. Estudio e tratamento do esqueleto fibroso: Fasicas e pompages. Summus Editorial, Sao Paulo 1995
5. Bienfait M. As basaes da fisiologia da terapia manual. Summus Editorial, Sao Paulo 1995.
6. Thiel W. Atlas topográfico de anatomía práctica. Volúmenes I y II Ed. Springer-Verlag Ibérica, Barcelona 2000.
7. Schleip R. Fascial plasticity-A new neurobiological explanation, Journal of Bodywork and Movement Therapy, 6 (4), 2002
8. Yahia L, et al. Sensory innervation of human thoracolumbar fascia. Acta Orthopaedica Scandinavica 63 (2): 195-197, 1992
9. Heppelman B, Messlinger K, Neiss, WF and Schmidt RF. Fine sensory innervation of the Knee Joint Capsule by group m and group rv nerve fibers in the cat. J Comparat Neurol, 251:415-428, 1995.
10. Andrzej Pilat, Terapias miofasciales: Inducción Miofascial, aspectos teóricos y aplicaciones clínicas. Ed. McGraw-Hill-Interamericana 2003 (ISBN:84-486-0559-4)
11. Yahia L, et al. Sensory innervation of human thoracolumbar fascia. Acta Orthopaedica Scandinavica 63 (2): 195-197, 1992
12. Barnes J. Myofascial Release. MFR seminars, Paoli, 1990
13. Schultz RL, Feitis R. The endless web, fascial anatomy and physical reality. Noth Atlantis Books, Berkeley, 1996
14. Coote JH, Perez González JF. The response of some sympathetic neurons to volleys in various afferent nerves. Journal of Physiology, London, 208:261-278, 1977
15. Kumazawa T, Mizumura K: Thin-fiber receptors responding to mechanical, chemical, and thermal stimulation in the skeletal muscle of the dog. J Physiol 1977, 273:179–194.
16. Mense S, Stahnke M: Responses in muscle afferent fibres ofslow conduction velocity to contractions and ischaemia in the cat. J Physiol 1983, 342:383–397.
17. Mense S, Meyer H: Different types of slowly conducting afferent units in cat skeletal muscle and tendon. J Physiol 1985, 363:403–417.
18. Lars Arendt-Nielsen,Thomas Graven-Nielsen, Central Sensitization in Fibromyalgia and Other Musculoskeletal Disorders; Current Pain and Headache Reports 2003, 7:355–361
19. "La Fibromialgia, los Trastornos Funcionales Digestivos y la Depresión" Universidad de la República Cátedra de Reumatología Dra. M. Moyano
20. Gordon Blackburn-Munro, Hypothalamo-Pituitary-Adrenal Axis Dysfunction As a Contributory Factor to Chronic Pain and Depression; Current Pain and Headache Reports 2004, 8:116–124
21. Andrzej Pilat, Terapias miofasciales: Inducción Miofascial, aspectos teóricos y aplicaciones clínicas. Ed. McGraw-Hill-Interamericana 2003, pag 29-30.
22. Andrzej Pilat, Terapias miofasciales: Inducción Miofascial, aspectos teóricos y aplicaciones clínicas. Ed. McGraw-Hill-Interamericana 2003, pag 42.
23. Baron JB, Ushio N, Noto R. Oculo-nuco-vestibulo-spinal system regulating tonic postura activity, statokinesimetric study. Agressologie, 15, 395-400, 1974.
24. Gagey PM, Le système postural fin. Dèfinition clínique. Ann. Kinésither., 20, 6, 289-294. 1993
25. Roll JP. Contribution de la propioception musculaire a la perpeption et au controle du mouvement chez l'homme. These Sci. Marseille, 1981.
26. FM Monograph, National Fibromyalgia Partnership, Inc. (NFP), 2001
27. Janda V. Muscle weakness and inhibition in back pain syndroms. Publicado en Grieve G P modern manual therapy of the vertebral column. Churchill Livingstone, Edinburgh, ch 19, 197, 1978
28. Rusell IJ, Fltcher EM, Michalek JE, Mc Broom PC, Hester GG Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam: double-blind, pacebo-controlled study. Arthritis Rheum 1991; 34: 552-560.
29. Yunus MB, Masi AT, Aldag JC Short term effects of ibuprofen in primary fibromyalgia syndrome: a double-blind, placebo controlled trial. J Rheumatol 1989; 16: 527-532.
30. Clark S, Tindall E, Bennett RM A double-blind cross-over trial of prednisone versus placebo in the treatment of fibrositis. J Rheumatol 1985; 12: 980-983.
31. Carette S, Bell MJ, Reynolds WJ, Haraoui B, McCain GA, Bykerk VP et al Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia: a randomized, doeble-blind clinical trial. Arthritis Rheum 1994; 37: 32-40.
32. Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL et al A prospective, longitudional, multicenter study of service utilization and costs in fibromyalgia (see comments). Arthritis Rheum 1997; 40: 1560-1570.
33. Fossaluza V, De Vita S Combined therapy with cyclobenzaprine and ibuprofen in primary fibromyalgia syndrome. Int J Clin Pharmacol Res 1992; 12: 99-102.
34. Wolfe F, Cathey MA, Hawley DJ A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol 1994; 23: 255-259.
35. Cantini F, BelllandiF, Niccoli L, Di Munno O Fluoxetin combined with cyclobenzaprine in the treatment of fibromyalgia (in Italian). Minerva Medica 1994; 85: 97-100.
36. Goldenberg DL, Mavssky M, Mossey C The independent and combined efficacy of fluoxetine and amitrityline in the treatment of fibromyalgia syndrome.
37. Ortho-McNeil Pharmaceutical, Carta a los profesionales de la salud, 3/20/96.

ENSAYO CLINICO

Wolfe F, Anderson j, Harkness D et al. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthtitis and Rheumatism 1997; 40: 1560-1570.

1. The Quality of Life Scale (QOLS):Reliability,Validity,and Utilization Carol S Burckhardt and Kathryn L Anderson Publicado el 23 October 2003 Health and Quality of Life Outcomes 2003,1 :60
2. Factors explaining variance in perceived pain in women with fibromyalgia. Eva Albertsen Malt, Snorri Olafsson, Anders Lund and Holger Ursin Publicado 25 April 2002 BMC Musculoskeletal Disorders 2002,3 :12
3. Magni G, Marchetti M, Moreschi C et al. Chronic musculoskeletal pain and depressive symptoms in the National Health and Nutritional Examination. I. Epidemiologic follow-up study. Pain 1993; 53: 163-168
4. Albornoz J, Povedano J, Quijada J, De la Iglesia JL , Fernández A, Pérez Vílchez D et al. Características clínicas y sociolaborales de la fibromialgia en España: descripción de 193 pacientes. Rev Esp Reumatol 1997; 24: 38-44.10bis. Méndez C, Prodanov A et al. Fibromialgia y Trastornos Digestivos Funcionales. XXII Congreso de Uruguayo de Reumatología. Piriápolis. 1998.
5. Alvarez-Lario B, Alonso-Valdivieso JL, Alegre López J, Viejo Bañuelos JL, Marañón-Cabello A. Sindrome de fibromialgia: características clínicas de las pacientes españolas. Rev Esp Reumatol 1996; 23: 76-82.